Neuberger Berman Group LLC Kala Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

  • $121 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 08, 2018
SELL
$12.26 - $18.98 $3.25 Million - $5.03 Million
-265,004 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$13.68 - $23.17 $2.94 Million - $4.98 Million
215,004 Added 430.01%
265,004 $4.9 Million
Q3 2017

Nov 15, 2017
BUY
$19.86 - $26.53 $993,000 - $1.33 Million
50,000
50,000 $1.14 Million

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.86M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email